Quantum BioPharma Ltd. is trading at $3.59 (-5.53%) today as shares face renewed pressure from the FDA clinical hold on its Lucid-MS IND application.
- The stock is extending a period of high volatility following the regulatory setback, which was initially announced earlier in June.
- Today's decline aligns with the company's history of sharp price swings and high volatility, occurring despite the absence of a broader market selloff.